Arzneimittelforschung, Table of Contents Arzneimittelforschung 2010; 60(11): 715-716DOI: 10.1055/s-0031-1300729 PMS-Symposium: Innovative Therapies in Hepatology Editio Cantor Verlag Aulendorf (Germany)Hepatische Enzephalopathie – neue Einblicke in die Zellbiologie und therapeutische Konsequenzen Dieter Häussinger Zentrum für Innere Medizin, Klinik für Gastroenterologie, Hepatologie und Infektiologie, Heinrich-Heine-Universität Düsseldorf› Author AffiliationsRecommend Article Abstract Buy Article Full Text References Literatur 1 Häussinger D, Laubenberger J, vom Dahl S et al. Proton magnetic resonance spectroscopy on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology. 1994; 107: 1475-80 2 Häussinger D, Kircheis G, Fischer R et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema. J Hepatol. 2000; 32: 1035-8 3 Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut. 2008; 57: 1156-5 4 Keitel V, Görg B, Bidmon HJ, Zemtsova I, Spomer L, Zilles K, Häussinger D. The bile acid receptor TGR5 (Gpbar-1) is a neurosteroid receptor in brain. Glia. 2010; in press 5 Görg B, Qvartskhava N, Keitel V et al. Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo . Hepatology. 2008; 48: 567-79 6 Görg B, Qvartskhava N, Bidmon H.J, Palomero-Gallagher N, Kircheis G, Zilles K, Häussinger D. Oxidative stress markers in the brain of cirrhotic patients with hepatic encephalopathy. Hepatology. 2010; 52: 256-65
